Authors:
DIEHL V
LOEFFLER M
PFREUNDSCHUH M
RUEHL U
HASENCLEVER D
NISTERSBACKES H
SIEBER M
SMITH K
TESCH H
GEILEN W
ADLER M
BARTELS H
BRANDENBURG U
DIEZLER P
DOELKEN G
ENZIAN J
FUCHS R
GASSMANN W
GERHARTZ H
HAGENAUKAMP U
HECHT T
HILLER E
HINKELBEIN H
LATHAN B
KIRCHNER H
KUEHN G
KUERTEN H
LOOS U
MAKOSKI B
OERTEL W
PETSCH S
PFAB R
PFLUEGER H
PLANKER M
ROHLOFF R
SACK H
SAMANDARI S
SAUER R
SCHALK K
SCHMITZ G
SCHOPPE W
SCHWIEDER G
SZEPESI S
TEICHMANN J
WILHELMY W
WORST P
FISCHER R
GEORGII A
HUEBNER K
SCHWARZE EW
Citation: V. Diehl et al., FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(9), 1995, pp. 901-910
Authors:
KAISARY AV
TYRRELL CJ
BEACOCK C
LUNGLMAYR G
DEBRUYNE F
ARKELL D
BAXTERSMITH D
BLACKLEDGE G
DIJKMAN GA
FARRAR D
KARTHAUS HFM
KHOE GS
KIL PJM
KUBER W
MARBERGER M
OSBORNE D
PFLUEGER H
PLASMAN J
PULL H
PUM H
SCHEPERS J
SCHORN A
SOLE G
STACKL W
URLESBERGER H
VILITS P
WALLACE DMA
DAWES PM
Citation: Av. Kaisary et al., A RANDOMIZED COMPARISON OF MONOTHERAPY WITH CASODEX 50 MG DAILY AND CASTRATION IN THE TREATMENT OF METASTATIC PROSTATE CARCINOMA, European urology, 28(3), 1995, pp. 215-222
Authors:
RIEDL CR
HUEBNER WA
MOSSIG H
OGRIS E
PFLUEGER H
Citation: Cr. Riedl et al., PROGNOSTIC VALUE OF PROSTATE-SPECIFIC ANTIGEN MINIMUM AFTER ORCHIECTOMY IN PATIENTS WITH STAGE-C AND STAGE-D PROSTATIC-CARCINOMA, British Journal of Urology, 76(1), 1995, pp. 34-40